Prostate Cancer Clinical Trials in Texas

Showing 101-120 of 133 trials

PSA-Activated PSA-PAH1 for Locally Recurrent Prostate Cancer

NCT00379561

This Phase 1 trial will evaluate the safety and tolerability of PSA-Activated PSA-PAH1 in subjects who have shown biochemical failure and have either completed at least one primary radiation therapy for prostate cancer and have evidence of recurrent local prostate cancer without metastases.

Prostate Cancer

Sophiris Bio Corp24 participantsStarted Mar 2006

Temple, Texas, United States

COMPLETEDPHASE355 miles

Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer

NCT00988208

The purpose of the study is to determine whether lenalidomide is safe and effective for use in combination with docetaxel and prednisone for the treatment of subjects with metastatic Castrate-Resistant Prostate Cancer. The addition of lenalidomide to docetaxel and prednisone is proposed to increase the life expectancy of these subjects.

Prostate Cancer

Celgene1,059 participantsStarted Nov 2009

Phoenix, Arizona, United States • Sedona, Arizona, United States • Tucson, Arizona, United States +207 more locations

PSA-Activated PSA-PAH1 for Locally Recurrent Prostate Cancer

Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer

Prostate Cancer Trials in Other Cities

Vidaza to Restore Hormone Thx Prostate

ClariCore System Used in Transrectal Ultrasound Guided Prostate Biopsy for Real-Time Tissue Evaluation

Return of Continence Following Robot-Assisted Radical Prostatectomy With or Without a Urethrovesical Sling

Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer

Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery

Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer

Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer

A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial)

A Phase 2 Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to Histopathology

Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer

Once-daily Oral Seviteronel in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone.

An Open-label Extension Study of PSMA ADC 2301 in mCRPC

Flutamide In the Prevention of Prostate Cancer in Patients With Neoplasia of the Prostate

Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy

Ixabepilone in Treating Patients With Metastatic Prostate Cancer

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

Multi-site Decision Impact Study for Decipher

Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Other Conditions in Texas